Medtronic Net Income (NCI) decreased by 14.3% to $6.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $9.00M to $6.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates that the company's majority-owned subsidiaries are generating more profit for their minority partners, which reduces the net income available to the parent company's shareholders.
This metric represents the portion of a subsidiary's net income that is attributable to minority shareholders who hold a...
Standard accounting line item for any company with partially owned consolidated subsidiaries.
minority_interest| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.00M | $6.00M | $4.00M | $2.00M | $8.00M | $6.00M | $6.00M | $2.00M | $15.00M | $6.00M | $9.00M | $9.00M | $7.00M | $7.00M | $6.00M |
| QoQ Change | — | +0.0% | -33.3% | -50.0% | +300.0% | -25.0% | +0.0% | -66.7% | +650.0% | -60.0% | +50.0% | +0.0% | -22.2% | +0.0% | -14.3% |
| YoY Change | — | — | — | -66.7% | +33.3% | +50.0% | +200.0% | -75.0% | +150.0% | +0.0% | +350.0% | -40.0% | +16.7% | -22.2% | -33.3% |